Flash Sensor Technologies Cutting-Edge Diagnostics in a Flash
Technology

Flash Sensor Technologies, Inc. (FST) is developing an electronic diagnostic platform for the point-of-care (POC) market. The market for protein biomarker based diagnosis is predominantly through blood samples sent to clinical laboratories. The new generation FST platform technology enables sensitive detection of specific biomarkers in complex samples such as serum, blood and saliva at the point-of-care, with sensitivity similar to clinical laboratory systems

Flash Sensor Technologies is developing a point-of-care diagnostic platform that has the following attributes:
  • 20 minute time to quanititative results
  • Protein based automated assay system
  • Broad array of analytes detectable
  • Small sample size
  • Low power requirements
  • Small footprint of reader
  • Disposable multiplexed to 6-12 samples
Pipeline
The versatile design of the FST electronic platform affords an impressively broad application range. Pipeline products currently under evaluation include personal-care diagnostics for celiac disease (immune response to wheat), autoimmune and infectious diseases, and cardiology. Keep your eye on this space for future developments!